Support Without a Cancer Diagnosis: Helping People at Risk Find Comfort

Those with a genetic predisposition to cancer can benefit from support groups as much as cancer patients, but options for the former group are limited. One man highlights the divide.

7:00 AM

Author | Shelley Zalewski

Kevin Myers is neither a cancer patient nor a cancer survivor.

Yet, in his 59 years, hardly a day has passed that hasn't been affected by the disease.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Myers was born with a genetic predisposition to colon cancer. His condition, familial adenomatous polyposis, or FAP, is one of a number of inherited colon cancer syndromes — including Lynch syndrome and MYH-associated polyposis (MAP).

About 3 percent of colon cancers are associated with these genetic syndromes, says Elena Stoffel, M.D., director of the Cancer Genetics Clinic at the University of Michigan Comprehensive Cancer Center.

"In patients with FAP, polyps develop in the colon as soon as early adolescence, numbering in the hundreds or even thousands," Stoffel says. "Without treatment, their risk of developing cancer exceeds 90 percent."

The alternative for most patients is just as overwhelming: the removal of the colon and life with an ostomy pouch.

Myers' colon was removed at age 14. Learning to live with an ileostomy — an opening in the abdominal wall made during surgery that allows digestive content to exit the body though a stoma into a pouch — made his youth especially tough.

"Although I've never been diagnosed with it, you could say my whole life has been defined by cancer," Myers says.

Still, he persevered through high school, college and graduate school, where he trained in social work and counseling — and where he met and married Brenda, his wife of 34 years.

To avoid passing on the FAP gene, the Myers pursued in vitro fertilization, giving birth to their daughter in 1995.

Strength in numbers

People living with these genetic syndromes might often feel isolated and marginalized. Resources and support groups available to cancer patients typically do not exist for people at high risk of cancer.

SEE ALSO: Collecting a Family's Cancer History: What You Should Ask

This was Myers' reality until a self-described "lightbulb moment" more than two years ago.

As he recalls, "I had enrolled in a clinical trial at the cancer center. Speaking with the study coordinator, I wondered aloud if there was such a thing as a support group for people like me."

When he found no such support network, Myers decided to take up the challenge himself that same day. It took nearly a year, but he realized his dream in May 2014 when about 20 patients and family members joined him for the first educational group meeting for people living with hereditary syndromes.

On April 20, Myers' support group will mark its second anniversary at the Cancer Support Community of Greater Ann Arbor (reservations recommended; see below for more details). He has also learned of another hereditary colorectal cancer group starting in Grand Rapids, Michigan.

The ongoing effort mirrors the founder's outlook on life.

Says Myers: "I've grown from considering my condition a curse to seeing it as an opportunity to make lemonade out of lemons."

Tips for starting your own support network

Want to form your own group? Myers offered suggestions based on his experience:

Go online: Connect with patients on social media. See what group activities are offered in other communities and find out how they got started.

Use existing resources: Myers reached out to the Hereditary Colon Cancer Foundation in Park City, Utah, for guidance — as well as the University of Michigan Rogel Cancer Center (which connected him with Stoffel) and the Cancer Support Community of Greater Ann Arbor.

Be patient: Although it didn't happen overnight for Myers, the results were worth the work and wait. "Connecting with people who really understand feels like coming home," he says. "And knowing that my experience might help someone else has made it all worthwhile."

More Articles About: Cancer Care Cancer and Genetics Cancer Risk Factors Cancer Counseling Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories cells colorful
Health Lab
Improvements in human genome databases offer a promising future for cancer research
A gene sequencing method called ribosome profiling has expanded our understanding of the human genome by identifying previously unknown protein coding regions. Also known as Ribo-seq, this method allows researchers to get a high-resolution snapshot of protein production in cells.
cancer cell
Health Lab
Language barriers in cancer care
Research from experts at Michigan Medicine shows that significant language-based disparities exist in patients’ access to cancer care services, and it’s well before their first appointment with a doctor. 
nanoparticles floating green blue
Health Lab
Gene therapy for brain tumor shows promising early results in humans
Research from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.
gloved hand doing microplate samples
Health Lab
Study brings insight to kidney cancer with gene mutation
A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.
dna strand
Health Lab
Research sheds new light on gene therapy for blood disorders
Research from experts at Michigan Medicine, the Children’s Hospital of Philadelphia and Penn Medicine is breaking ground on new ways of treating blood disorders, such as sickle cell anemia, through gene therapy.
money pills cancer vial yellowArtboard
Health Lab
Changing the way immune-based cancer drugs are delivered could reduce costs by 14%
An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.